Integrated Transcriptome Analysis of LncRNA, MiRNA, and MRNA Reveals Key Regulatory Modules for Polycystic Ovary Syndrome
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-024-00183-9.
References
1.
Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H
. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril. 2017; 107(6):1380-1386.e1.
DOI: 10.1016/j.fertnstert.2017.04.011.
View
2.
De Leo V, La Marca A, Petraglia F
. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev. 2003; 24(5):633-67.
DOI: 10.1210/er.2002-0015.
View
3.
Dweep H, Gretz N
. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015; 12(8):697.
DOI: 10.1038/nmeth.3485.
View
4.
Jiao J, Shi B, Wang T, Fang Y, Cao T, Zhou Y
. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome. Hum Reprod. 2018; 33(9):1735-1748.
DOI: 10.1093/humrep/dey255.
View
5.
Shannon C, Chen V, Takhar M, Hollander Z, Balshaw R, McManus B
. SABRE: a method for assessing the stability of gene modules in complex tissues and subject populations. BMC Bioinformatics. 2016; 17(1):460.
PMC: 5109843.
DOI: 10.1186/s12859-016-1319-8.
View